Stay updated on Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page.

Latest updates to the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page
- Check2 days agoChange DetectedA new revision entry labeled v3.5.4 was added to the history and the previous v3.5.3 entry was removed, updating the page's revision metadata.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page’s software/version revision indicator was updated from v3.5.2 to v3.5.3, reflecting a general release-level change rather than an update to the trial history or study details.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the record history.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.5.0 was added and revision v3.4.3 was removed.SummaryDifference0.1%

- Check66 days agoChange DetectedThe latest version adds a 'Study Status' entry to the history (revision v3.4.3, dated 2026-03-11); the prior revision (v3.4.2, 2025-12-24) is removed.SummaryDifference0.3%

- Check95 days agoChange DetectedThe page history shows a new site revision (v3.4.2) was added, and an old funding-notice and a previous revision (v3.4.1) were removed.SummaryDifference0.5%

Stay in the know with updates to Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page.